SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) March 30, 1998
Uroplasty, Inc.
(Exact name of registrant as specified in its charter)
Minnesota 000-20989 41-1719250
(State or other juris- (Commission File (IRS Employer
diction of incorporation) Number) Identification No.)
2718 Summer Street N.E., Minneapolis, Minnesota 55413
(Address of principal executive offices) (Zip Code)
Registrant`s telephone number, including area code: (612) 378-1180
Not applicable
(Former name or former address, if changed since last report)
Item 5. Other Events.
Uroplasty, Inc., Minneapolis, Minnesota, announced today that it proposes to
make a private placement of its common stock for a period of up to 60 days
commencing in late April or early May 1998. Uroplasty, Inc. will seek to
raise in this private placement up to approximately $4,000,000 in gross
proceeds.
The securities are being offered pursuant to an exemption from registration
and contain certain registration rights. The securities may not be offered
or sold in the United States absent registration or an applicable exemption
from registration.
This announcement shall not constitute an offer to sell or the solicitation
of an offer to buy nor shall there be any sale of these securities in any
State in which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such State.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
UROPLASTY, INC.
Dated: March 30, 1998 By: /s/ Daniel G. Holman
Daniel G. Holman, President, CEO
